Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing

Patent metadata

Field	Value
Publication number	US-10662474-B2
Application number	US-201113009718-A
Country	US
Kind code	B2
Filing date	Jan 19, 2011
Priority date	Jan 19, 2010
Publication date	May 26, 2020
Grant date	May 26, 2020

Abstract

The present invention relates to methods comprising whole genome sequencing for identifying polymorphisms in samples comprising mixtures of genomes, and for determining and/or monitoring the presence or absence of disorders associated with the identified polymorphisms.

First claim

What is claimed is:

1. A method for identifying multiple fetal polymorphisms in a fetal genome of a blood sample obtained from a pregnant woman comprising a mixture of cfDNA of a fetal and a maternal genome, said method comprising steps:
(a) performing whole genome sequencing on at least a portion of said mixture of cfDNA, thereby obtaining a plurality of sequence tags, wherein said mixture is unenriched for said multiple polymorphisms, and wherein said sequencing is massively parallel sequencing of clonally amplified cfDNA molecules or of single cfDNA molecules;
(b) mapping the sequences of said plurality of sequence tags to the sequences of multiple reference polymorphisms, to identify sequence tags mapped to each of said multiple reference polymorphisms;
(c) for each of said multiple reference polymorphisms;
(i) quantifying mapped sequence tags that map to a first allele of the reference polymorphism to obtain a quantitative value for the first allele;
(ii) quantifying mapped sequence tags that map to the second allele of the reference polymorphism to obtain a quantitative value for the second allele;
(iii) determining a parameter from the quantitative value for the first allele and the quantitative value for the second allele;
(iv) comparing the parameter to one or more cutoff values associated with the relative abundance of fetal cfDNA in the material sample; and
(v) classifying each allele as a (i) minor allele or (ii) major allele, based on the comparison of the parameter to the one or more cutoff values:
whereby a minor allele is identified as a fetal polymorphism in the maternal sample:
wherein the identification of fetal polymorphisms originating from the fetal genome in the mixture is performed without genotyping the maternal alleles in a maternal sample that is substantially free of fetal nucleic acids.

2. The method of claim 1 , wherein said multiple fetal polymorphisms in said fetal genome are associated with at least one disorder.

3. The method of claim 1 , wherein each of said multiple fetal polymorphisms comprise at least one single nucleotide polymorphism (SNP), a tandem SNP, or a short tandem repeat (STR).

4. The method of claim 3 , wherein said at least one SNP is a tag SNP.

5. The method of claim 3 , wherein said at least one STR is a tag STR.

6. The method of claim 1 , wherein said sequencing is massively parallel sequencing of clonally amplified cfDNA molecules.

7. The method of claim 1 , wherein said sequencing is performed using massively parallel sequencing-by-synthesis with reversible dye terminators.

8. The method of claim 1 , wherein said sequencing is performed using massively parallel sequencing-by-ligation.

9. The method of claim 1 , wherein said sample is a plasma sample.

10. A method of identifying fetal alleles in a maternal sample, comprising:
(a) performing massively parallel whose genome sequencing on a mixture of fetal and maternal cfDNA from a maternal sample, and providing digital sequence information comprising sequence reads obtained from the massively parallel whole genome sequencing,
wherein the digital sequence information comprises a plurality of polymorphic sequence reads; and
wherein said multiple polymorphic sequence are not specifically enriched in said mixture;

(b) mapping a plurality of the sequence reads to polymorphic sites in a reference genome to obtain a plurality of mapped sequence tags;
(c) for each of a plurality of polymorphic sites in the reference genome:
(i) quantifying mapped sequence tags that map to a first allele of the polymorphic site to obtain a quantitative value for the first allele;
(ii) quantifying mapped sequence tags that map to the second allele of the polymorphic site to obtain a quantitative value for the second allele;
(iii) determining a parameter from the quantitative value for the first allele and the quantitative value for the second allele;
(iv) comparing the parameter to one or more cutoff values associated with the relative abundance of fetal cfDNA in the maternal sample; and
(v) classifying each allele at the polymorphic site as a (i) minor allele or (ii) major allele, based on the comparison of the parameter to the one or more cutoff values;
whereby a minor allele is identified as a fetal allele in the maternal sample;
wherein the identification of fetal alleles is performed without genotyping the maternal alleles in a maternal sample that is substantially free of fetal nucleic acids.

Assignees

• Rava Richard P
• Verinata Health Inc

Inventors

• Rava Richard P

Classifications

• C12Q2600/16

  Primer sets for multiplex assays · CPC title

• C12Q1/6886

  for cancer (immunoassay for cancer G01N33/575) · CPC title

• C12Q1/6827

  for detection of mutation or polymorphism · CPC title

• C12Q2600/172

  Haplotypes · CPC title

• C12Q1/6883 Primary

  for diseases caused by alterations of genetic material · CPC title